Insight Molecular Diagnostics Inc. 8-K

What Happened
Insight Molecular Diagnostics, Inc. (iMDx) announced and furnished a press release on March 26, 2026 reporting its financial results for the three months and the twelve months ended December 31, 2025. The company filed an 8-K (Item 2.02) to disclose these results and included the press release as Exhibit 99.1 to the filing.

Key Details

• Filing date: March 26, 2026 (Form 8-K, Item 2.02).
• Reporting periods covered: three months and twelve months ended December 31, 2025.
• Press release describing the results was furnished as Exhibit 99.1 to the 8-K.
• The 8-K also includes the Interactive XBRL cover page (Inline XBRL) as part of the filing package.

Why It Matters
This 8-K gives investors the company’s most recent quarterly and full-year results; those figures (revenue, profit/loss, cash and operational metrics) are detailed in the press release. Investors should read the furnished press release for the specific financial numbers and management commentary, as those results may influence near‑term valuation and investment decisions.